Michael St. Andre
Pfizer (United States)(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Mesenchymal stem cell research, Mitochondrial Function and Pathology, Nutrition and Health in Aging, Parathyroid Disorders and Treatments
Most-Cited Works
- → A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys(2017)99 cited
- → Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy(2011)58 cited
- → Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody(2016)51 cited
- → Treatment with rhBMP12 or rhBMP13 increase the rate and the quality of rat Achilles tendon repair(2011)39 cited
- → 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators(2014)18 cited
- → Mice treated with a myostatin/GDF-8 decoy receptor, ActRIIB-Fc, exhibit a tremendous increase in bone mass(2008)16 cited
- → DUX4 expression activates JNK and p38 MAP kinases in myoblasts(2022)16 cited
- [Neonatal hyperparathyroidism secondary to maternal hypoparathyroidism (author's transl)].(1980)
- [Primary cardiomyopathy in children with lipid infiltration of the myocardium and skeletal muscles and demonstration of a palmityl-carnitine transferase deficiency. Apropos of 4 cases].(1979)
- → T.P.39 Building muscle with myostatin inhibitors(2012)